Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Finance

KKR outbids Advent in $6.5 billion battle to buy UK's Spectris

Published by Global Banking and Finance Review

Posted on July 2, 2025

Featured image for article about Finance

(Reuters) -British scientific instruments maker Spectris has agreed to a takeover offer from U.S. investment firm KKR valuing it at 4.7 billion pounds ($6.46 billion) including debt, and has withdrawn its support for a rival offer from Advent.

The battle for Spectris, Britain's largest takeover target this year, heated up after KKR last week tabled a bid valuing Spectris at 40 pounds per share including dividends, 6.3% higher than Advent's 37.63 pound per share offer, which valued the group at 4.4 billion pounds.

Spectris said its board has decided to withdraw its recommendation of Advent's offer in favour of the higher bid from KKR, which had made two prior takeover proposals for the London-listed firm. The firm had rejected KKR's second takeover bid on June 13.

Advent, which had reserved the right to increase its offer for Spectris if a competing bid was made, did not immediately respond to Reuters' request for a comment.

"The ball is now back in Advent's court, and having stalked Spectris for an extended period, there must be some chance that it keeps fighting," analysts at Stifel said.

"But having already raised its bid several times, room for manoeuvre looks fairly limited to us."

Spectris shares climbed as much as 5.3% to 40.32 pounds on Wednesday to their highest in more than three and a half years. As of Tuesday's close the stock had surged nearly 88% since Advent's initial bid was disclosed on June 9.

In its latest offer for Spectris, shareholders will receive 39.72 pounds per share in cash from KKR and an interim dividend of 28 pence.

Britain's cheap valuations and relative stability have lured overseas buyers. KKR was also involved in a bidding war for British healthcare real estate investor Assura, which agreed a deal with KKR-Stonepeak before ditching them in favour of a higher bid from Primary Health Properties last month.

($1 = 0.7281 pounds)

(Reporting by Raechel Thankam Job in Bengaluru; Editing by Eileen Soreng, Sherry Jacob-Phillips and Jan Harvey)